May 2, 2023 02:39 PM EDT
AI
Pharma
Manufacturing

Boehringer and Lon­za ques­tion the fu­ture of FDA's reg­u­la­tion of AI in man­u­fac­tur­ing

Tyler Patchen

News Reporter

The FDA opened the floor for com­ments on its dis­cus­sion pa­per on the use of AI in drug man­u­fac­tur­ing, with in­ter­est groups and man­u­fac­tur­ers in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Boehringer’s up­dat­ed re­sults in HER2-mu­tat­ed lung can­cer im­press

No­vavax re­sponds to FDA’s tri­al ask, with Covid vac­cine strain up­dates un­der scruti­ny

Schol­ar Rock names new CEO, adds biotech vet­er­ans in C-suite re­build

Mer­ck KGaA to buy rare can­cer biotech Spring­Works for $3.9B

Ex­clu­sive: Can AI re­place an­i­mal test­ing? A new biotech launch­es to find out

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times